Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Goodwill (2016 - 2025)

Historic Goodwill for Veracyte (VCYT) over the last 12 years, with Q3 2025 value amounting to $767.2 million.

  • Veracyte's Goodwill rose 66.7% to $767.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $767.2 million, marking a year-over-year increase of 66.7%. This contributed to the annual value of $745.8 million for FY2024, which is 609.06% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's Goodwill is $767.2 million, which was up 66.7% from $773.3 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Goodwill peaked at $773.3 million during Q2 2025, and registered a low of $471.8 million during Q2 2021.
  • Moreover, its 5-year median value for Goodwill was $704.4 million (2022), whereas its average is $696.8 million.
  • Its Goodwill has fluctuated over the past 5 years, first soared by 2611185.32% in 2021, then crashed by 523.23% in 2022.
  • Over the past 5 years, Veracyte's Goodwill (Quarter) stood at $707.9 million in 2021, then dropped by 1.7% to $695.9 million in 2022, then grew by 1.02% to $703.0 million in 2023, then rose by 6.09% to $745.8 million in 2024, then rose by 2.87% to $767.2 million in 2025.
  • Its Goodwill stands at $767.2 million for Q3 2025, versus $773.3 million for Q2 2025 and $754.3 million for Q1 2025.